Back to Search
Start Over
Eli Lilly price target raised by $150 at BofA, here's why
- Source :
- The Fly. August 9, 2024
- Publication Year :
- 2024
-
Abstract
- BofA raised the firm's price target on Eli Lilly to $1,150 from $1,000 and keeps a Buy rating on the shares following the continued outperformance from Lilly's incretin portfolio, including [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.804339958